CTLA4 and neoplasm: As mentioned in the preceding paragraphs, tumors promote the formation of highly immunosuppressive TMEs, preventing the generation of effective anti-tumor immune response through multiple mechanisms such as limiting T cell effector functions by engaging PD-1 and CTLA-4 [7,8].